Teva launches generic version of EpiPen for kids

Alia Paavola - Print  | 

Teva Pharmaceuticals has launched its generic version of Mylan's EpiPen Jr., the lifesaving allergy treatment for young children.

The generic EpiPen Jr. auto-injector will be available in most retail pharmacies across the U.S. at a price of $300 for a two-pack.

Teva already launched the EpiPen generic for adults after securing FDA approval on the product last August.

There has been a shortage of EpiPens in the U.S. and Mylan warned in June it expects shortages to continue.

More articles on pharmacy:
CMS to cover CAR-T therapy nationwide
Colombia fines Pfizer $25K for drug price inflation
Jefferson Healthcare opens retail specialty pharmacy

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.